There is an expanded CD8+CD38hi T cell population in a group of SLE patients with recurring infections that are characterized by decreased granzyme-dependent cytotoxicity and an impaired NAD+ production in a NAD/SIRTUIN1/EZH2 axis (62). The gene discussed is EZH2; the disease is systemic lupus erythematosus.